🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07309809
Starting soon Not applicable

Portrait Mobile Monitoring Solution V2.0 External Evaluation

NCT07309809 · tracked via the Priya Life Science UK tracker
Sponsor
GE Healthcare
Phase
Not applicable
Started
2026-07
Last updated
2026-06-10

Condition(s) studied

Monitoring

Investigational drug(s) / intervention(s)

Continuous Monitoring

Continuous Monitoring: Subjects will have vital signs continuously monitored for up to 72 hours with the study device

Study summary

The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development, including engineering purposes as deemed appropriate by the Sponsor.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Participant is age 18 years or older (≥18 years). 2. Participant must have the ability to understand and provide written informed consent. 3. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure. 4. Participant must be willing and able to comply with study procedures and duration. Exclusion Criteria: 1. Known to be pregnant and/or breast feeding. 2. Diagnosed with infection requiring isolation. 3. Are immunocompromised. 4. Have previously participated in this study (no subject may participate more than once). 5. Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West Middlesex University Hospital London England

More GE Healthcare trials in the UK

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07309809 on ClinicalTrials.gov ↗ ← All trials in the UK